Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Synchronous and metachronous skeletal osteosarcomas: The Norwegian Radium Hospital experience
Acta Oncologica, 10/26/09
Brandal P et al. – The prognosis for patients with synchronous and metachronous skeletal osteosarcoma is poor. However, because long–term survival is seen, aggressive treatment to selected cases, e.g., patients with an osteosarcoma predisposing syndrome and/or late occurring metachronous tumours, is justified. Revealing a possible clonal relationship between these tumors, e.g., by karyotyping, may be of interest for estimating prognosis and guide therapy intensiveness.
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
A phase 2 trial exploring the effects of high-dose (10,000 IU/day) Vitamin D3 in breast cancer patients with bone metastases
Cancer, 11/25/09
Endoprosthetic proximal femur replacement: Metastatic versus primary tumors
Surgical Oncology, 11/05/09
Survival in high-grade osteosarcoma: improvement over 21 years at a single institution
Annals of Oncology, 11/16/09
Article Search
Sponsor


See Latest Articles


